INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR
1ISRG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 64 industry peers in the Health Care Equipment & Supplies industry. 1ISRG gets an excellent profitability rating and is at the same time showing great financial health properties. 1ISRG is valued quite expensive, but it does show an excellent growth. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
In the past 5 years 1ISRG has always been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1ISRG (12.88%) is better than 92.19% of its industry peers.
The Return On Equity of 1ISRG (14.47%) is better than 81.25% of its industry peers.
The Return On Invested Capital of 1ISRG (10.45%) is better than 81.25% of its industry peers.
1ISRG had an Average Return On Invested Capital over the past 3 years of 10.24%. This is in line with the industry average of 8.65%.
The last Return On Invested Capital (10.45%) for 1ISRG is above the 3 year average (10.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROIC | 10.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1.3 Margins
1ISRG's Profit Margin of 28.41% is amongst the best of the industry. 1ISRG outperforms 95.31% of its industry peers.
1ISRG's Profit Margin has declined in the last couple of years.
1ISRG has a Operating Margin of 28.28%. This is amongst the best in the industry. 1ISRG outperforms 98.44% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG has a better Gross Margin (67.09%) than 68.75% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
1ISRG has more shares outstanding than it did 5 years ago.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
1ISRG has an Altman-Z score of 58.57. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
1ISRG's Altman-Z score of 58.57 is amongst the best of the industry. 1ISRG outperforms 98.44% of its industry peers.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 58.57 |
ROIC/WACC1.14
WACC9.15%
2.3 Liquidity
A Current Ratio of 4.98 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG's Current ratio of 4.98 is amongst the best of the industry. 1ISRG outperforms 93.75% of its industry peers.
A Quick Ratio of 3.97 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a Quick ratio of 3.97. This is amongst the best in the industry. 1ISRG outperforms 95.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 |
3. Growth
3.1 Past
1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.76%, which is quite impressive.
The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
Looking at the last year, 1ISRG shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.45% on average per year.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 73.02, the valuation of 1ISRG can be described as expensive.
1ISRG's Price/Earnings ratio is in line with the industry average.
1ISRG is valuated expensively when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 60.52, which means the current valuation is very expensive for 1ISRG.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.30. 1ISRG is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.02 | ||
| Fwd PE | 60.52 |
4.2 Price Multiples
1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 64.06% of the companies in the same industry.
1ISRG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 114.65 | ||
| EV/EBITDA | 64.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 13.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.26
PEG (5Y)6.36
EPS Next 2Y12.18%
EPS Next 3Y13.88%
5. Dividend
5.1 Amount
No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (5/29/2025, 7:00:00 PM)
489.25
-10.2 (-2.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap175.36B
Analysts79.49
Price Target526.29 (7.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)2.47%
PT rev (3m)-15.2%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.02 | ||
| Fwd PE | 60.52 | ||
| P/S | 22.96 | ||
| P/FCF | 114.65 | ||
| P/OCF | 73.26 | ||
| P/B | 11.7 | ||
| P/tB | 11.95 | ||
| EV/EBITDA | 64.55 |
EPS(TTM)6.7
EY1.37%
EPS(NY)8.08
Fwd EY1.65%
FCF(TTM)4.27
FCFY0.87%
OCF(TTM)6.68
OCFY1.36%
SpS21.31
BVpS41.83
TBVpS40.93
PEG (NY)8.26
PEG (5Y)6.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROCE | 13.94% | ||
| ROIC | 10.45% | ||
| ROICexc | 14.17% | ||
| ROICexgc | 14.58% | ||
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% | ||
| FCFM | 20.03% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 185.49% | ||
| Cap/Sales | 11.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.16% | ||
| Profit Quality | 70.49% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 | ||
| Altman-Z | 58.57 |
F-Score6
WACC9.15%
ROIC/WACC1.14
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%